Global Elastomeric Infusion Pumps Market Trends and Opportunities 2024

"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!

The new report published by The Business Research Company, titled Elastomeric Infusion Pumps Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the elastomeric infusion pumps market size has grown strongly in recent years. It will grow from $0.98 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%.

Download Free Sample Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=18584&type=smp

What Is Driving The Growth Of The Global Elastomeric Infusion Pumps Market?

Rising Hospitalization Rates Drives Growth In The Elastomeric Infusion Pumps Market
The growing rate of hospitalized patients is expected to propel the growth of the elastomeric infusion pump market going forward. Hospitalized patients are people who are admitted to a hospital for medical treatment and care, which require ongoing monitoring and specific interventions. Advances in medical technology have made more complex and effective treatments available, leading to increased hospital admissions for surgeries and procedures. Elastomeric infusion pumps allow patients to continue receiving necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This enables early discharge, freeing up hospital beds for other patients and reducing hospital occupancy rates. For instance, in December 2023, according to a report published by the National Health Service (NHS), a UK-based government department, there were 408,700 hospital admissions in 2022-2023, reflecting a 5% increase from 389,800 hospital admissions in 2021-2022 in England. Therefore, the growing rate of hospitalized patients will drive the elastomeric infusion pump market.

What Is The Key Trend In The Global Elastomeric Infusion Pumps Market?

Advancements In Elastomeric Infusion Pumps For Enhanced Drug Delivery
Major companies operating in the elastomeric infusion pump market are developing portable chemotherapy infusion pumps to provide more reliable and user-friendly infusion systems and enhance precision in drug delivery. Chemotherapy portable infusion pumps are devices that deliver chemotherapy drugs in a controlled manner, allowing patients to receive continuous or intermittent treatment outside of a hospital setting. For instance, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a China-based medical device company, launched AutoEx. The AutoEx is designed for the continuous or intermittent infusion of chemotherapy drugs, facilitating precise drug delivery to patients with malignancies. It features a dual CPU control system and a disposable pump infusion unit that includes two fluid reservoir bags, allowing automatic switching between them to ensure uninterrupted medication delivery. This design enhances patient comfort and reduces the need for healthcare professionals to intervene manually. AutoEx in the traditional sense, operates within the same therapeutic space of elastomeric infusion pump.

How Is The Global Elastomeric Infusion Pumps Market Segmented?
The elastomeric infusion pumps market covered in this report is segmented -

1) By Product Type: Continuous Rate Elastomeric Pumps, Variable Rate Elastomeric Pumps
2) By Treatment: Pain Management, Antibiotic Or Antiviral, Chemotherapy, Other Treatments
3) By End-User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, Other End-Users

You Can Pre-Book The Global Market Report Of Your Requirement For A Swift Delivery And Also Get An Exclusive Discount On This Report, Checkout Link:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18584

How Is The Competitive Landscape Of The Global Elastomeric Infusion Pumps Market?
Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd

Contents Of The Global Elastomeric Infusion Pumps Market
1. Executive Summary
2. Elastomeric Infusion Pumps Market Report Structure
3. Elastomeric Infusion Pumps Market Trends And Strategies
4. Elastomeric Infusion Pumps Market - Macro Economic Scenario
5. Elastomeric Infusion Pumps Market Size And Growth
…..
27. Elastomeric Infusion Pumps Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore The Report Store To Make A Direct Purchase Of The Report: https://www.thebusinessresearchcompany.com/report/elastomeric-infusion-pumps-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.